Otsuka Pharmaceutical Factory

What Otsuka Pharmaceutical Factory does

Otsuka Pharmaceutical Factory is a Japan-based, privately held pharmaceutical manufacturer founded in 1969 and headquartered in Naruto City, Tokushima Prefecture, operating as the originating company of the Otsuka Group under parent Otsuka Holdings (大塚ホールディングス). The company is structured around clinical nutrition, producing intravenous (IV) solutions (Elneopa NF輸液, Intralipos fat emulsions), enteral nutrition formulas (Racol NF, Inoras, ENSOLID), oral rehydration solutions (OS-1シリーズ), semi-solid and concentrated nutritional foods (HINEX series including HINEX Jelly Aqua, Rehadays, ProcessLead, Engelead, GFO, InnerPower), antiseptic and disinfectant cartridge medical devices (Povidone-iodine 10% and Oranejin 1.5% cartridges used with a separately sold applicator), urinary catheters (Actreen), oral care products (Hinora series), and the legacy OTC product Oronine H ointment. It complements this portfolio with digital health services, including the Pocke-Nyu (ぽけにゅー) cloud food/nutrition support service and the Nurtal (にゅーたる) nutrition management visualization app.

The company's product strategy is built on vertically integrated formulation and container technology, with an R&D footprint spanning drug discovery (Naruto Research Institute), product/clinical development (Medical Affairs Department), formulation science, and proprietary container design. Under the management vision "The Best Partner in Clinical Nutrition Worldwide," Otsuka Pharmaceutical Factory addresses the full care continuum from dehydration prevention through hospital IV therapy, rehabilitation nutrition, and home parenteral/enteral nutrition (HPN/HEN).

The revenue model is a hybrid prescription-and-OTC operation. Prescription pharmaceuticals, medical foods, and medical devices are sold primarily through a medical representative (MR) sales force engaging hospitals, clinics, pharmacists, and home care providers, with pricing administered under Japan's national health insurance (e.g., the Povidone-iodine 10% disinfectant cartridge at ¥16.80/25mL, HINEX Jelly Aqua at ¥330/300kcal bag ex-tax). OTC revenue flows through pharmacy networks and retail (Oronine H). Customer segments split between medical institutions (primary), home care patients (HPN/HEN and self-catheterization), and general consumers for OTC. Distribution is overwhelmingly domestic Japan, with international expansion cited as an ambition via Otsuka Group channels.

Name

Otsuka Pharmaceutical Factory

Legal name

株式会社大塚製薬工場

Website

https://otsukakj.jp

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Otsuka Pharmaceutical Factory is a Japanese clinical nutrition company and Otsuka Group subsidiary that manufactures IV solutions, enteral and medical foods, antiseptic cartridges, and oral care products, selling primarily to hospitals, home care patients, and pharmacies in Japan via medical representatives and retail.

Ownership category

akta.pro rank

Product category

Clinical Nutrition and IV Solutions

NAICS

Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

Keywords

• IV solutions
• Clinical nutrition products
• Enteral nutrition
• Medical foods
• Surgical disinfectants

Headquarters

HQ city

Tokushima

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical Products: Prescription pharmaceuticals including IV solutions,输液 (fluids), and medical solutions sold to hospitals and medical institutions
2. Medical Foods (Medicinal Foods): Scientifically developed medical foods including OS-1 oral rehydration, HINEX concentrated liquids, and enteral nutrition products
3. OTC Pharmaceuticals: Over-the-counter products including Oronine H ointment sold through retail pharmacies
4. Medical Devices: Medical devices including disinfection agents, antiseptic cartridges, and urinary catheters
5. Oral Care Products: Oral care products including Hinora series

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels2 records

Core offering

Otsuka Pharmaceutical Factory manufactures, distributes, and sells clinical nutrition medical products, including IV (infusion) solutions, parenteral and enteral nutrition, oral rehydration and medical foods, medical devices such as surgical disinfectant cartridges and catheters, OTC ointments, oral care products, and digital nutrition-management services for healthcare settings from hospital to home care.

Product overview

Otsuka Pharmaceutical Factory operates as a clinical nutrition-focused pharmaceutical company offering an integrated portfolio of medical pharmaceuticals, medical devices, Medical Foods, OTC products, and digital health services. The product portfolio centers on IV solutions (Elneopa NF, Intralipos fat emulsions), enteral nutrition formulas (Racol NF, Inoras, Inosolid), and oral rehydration/nutrition products (OS-1, HINEX series). Peripheral offerings include disinfectant products (Povidone Iodine, Oranejin cartridges) and oral care products (Hinora). The company also provides digital health solutions including the Pocke-Nyu cloud nutrition support service and Nurtal nutrition management app. The architecture follows a multi-product strategy combining pharmaceutical/medical device offerings with supporting digital services to address the full clinical nutrition care pathway from hospital to home care.

Differentiator

Problem solved

Functional benefit

Brands

• OS-1 (オーエスワン) シリーズ: Oral rehydration solution (ORS) product line for medical and clinical settings
• Hinex (ハイネックス) シリーズ
• Rehadays (リハデイズ)
• ProcessLead (プロセスリード)
• Engelead (エンゲリード)
• GFO (ジーエフオー)
• InnerPower (インナーパワー)
• Oronine H (オロナインH) 軟膏
• Hinora (ヒノーラ) シリーズ
• ぽけにゅー (Pock Nyu)
• にゅーたる (Nurtal)

Products and services

• OS-1 (オーエスワン) Series Oral rehydration solution (ORS) product line for fluid and electrolyte replacement in clinical and medical settings.
• HINEX (ハイネックス) Series Concentrated liquid and semi-solid nutritional food series for patients requiring clinical nutrition management, including standard formulas, low-calcium options, and moisture-adjusted formulations.
• Racol NF (ラコールNF) Series Complete enteral nutrition liquid and semi-solid formulas for tube feeding, providing balanced macronutrients and micronutrients for patients unable to meet nutritional needs orally.
• Inoras (イノラス) Enteral Nutrition Enteral nutrition formula designed to support patients requiring tube feeding with specialized nutritional composition.
• ENSOLID Specialized enteric nutrition product incorporating L-carnitine for clinical and geriatric settings.
• Elneopa NF (エルネオパNF) IV Peripheral and central venous nutrition solutions for intravenous nutritional support in hospital and home healthcare settings.
• Intralipos (イントラリポス) IV 10%/20% Intravenous fat emulsion providing essential fatty acids and calories for patients requiring parenteral nutrition.
• Povidone Iodine Disinfectant Cartridge (ポビドンヨード液) 10% povidone-iodine antiseptic solution in 25mL cartridge format for surgical site skin and mucous membrane disinfection.
• Oranejin (オラネジン液) Disinfectant Series 1.5% antiseptic solution cartridge series in standard and orange-tinted (OR) formulations for surgical site skin disinfection, used with cartridge applicator.
• Actreen (アクトリーン) Intermittent Catheter Intermittent urological catheter for clean self-catheterization in patients with urinary retention or neurogenic bladder.
• Oronine H (オロナインH) Ointment Over-the-counter topical ointment for minor cuts, burns, and skin infections.
• Hinora (ヒノーラ) Series Oral care product line for maintaining oral hygiene, particularly in clinical and care settings.
• Processlead (プロセスリード) Chewing initiation food designed to support patients in resuming oral eating, developed for clinical nutrition settings.
• Rehadays (リハデイズ) Medical nutrition product designed for rehabilitation support.
• Pocke-Nyu (ぽけにゅー) Cloud-based food and nutrition support service for home medical care, providing meal and nutrition assessment functions and multidisciplinary information sharing for patients with nutritional challenges.
• Nurtal (にゅーたる) Mobile application for visualizing nutrition management, supporting healthcare providers and patients in tracking nutritional intake and status.

Quantifiable outcome

• Products used across prevention, hospital, rehabilitation, and home care settings

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Nature.comminorGTM or Marketing PartnerMedical Affairs department activities were featured as advertisement article in Nature.com (March 2026)
• 全国訪問看護事業協会 (Japan Visiting Nursing Association)coreStrategic or Co-development PartnerCollaborated with the association for survey on oral and nutritional care in home care settings, surveying 497 visiting nursing stations nationwide
• 大塚製薬株式会社 (Otsuka Pharmaceutical Co., Ltd.)coreChannel Partner/ Reseller/ DistributorSales partnership for OTC products and marketing collaboration within Otsuka Group

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Abbott Nutrition: Major global clinical and medical nutrition player with enteral feeding products, comparable to Otsuka's HINEX, Racol, and OS-1 franchises.
• Nestlé Health Science: Global medical nutrition leader with overlapping enteral and oral nutritional supplements, comparable to Otsuka's medical foods business.
• Terumo Corporation: Large Japanese medical device and pharmaceutical company with overlapping infusion systems, hospital products, and clinical nutrition adjacencies in the domestic market.
• ICU Medical: Broad medical device and IV therapy incumbent with overlapping infusion, disinfection, and catheter products relevant to Otsuka's medical devices franchise.

Regional players

• JMS Co., Ltd. Japan-based manufacturer of IV solutions, infusion sets, and medical devices—directly comparable regionally to Otsuka Pharmaceutical Factory's hospital IV business.

Direct peers

• Grifols: Named alongside Otsuka Pharmaceutical Factory as a major player in the global IV hydration therapy and clinical nutrition market.
• B. Braun SE: Major player in IV solutions, infusion therapy, and clinical nutrition globally, competing head-to-head in the same IV hydration therapy market.
• Baxter International: Global leader in IV solutions, IV bags, and clinical nutrition—directly comparable as one of the named IV therapy majors alongside Otsuka Pharmaceutical Factory.
• Fresenius Kabi: Specializes in clinical nutrition, IV fluids, and enteral/parenteral feeding products—closely overlapping with Otsuka's IV and enteral nutrition portfolio.

Others

• Otsuka Pharmaceutical Co., Ltd. Sister company under Otsuka Holdings with OTC distribution and marketing partnership; comparable in OTC/consumer health but broader therapeutic focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Otsuka Pharmaceutical Factory